Home › Compare › RARMF vs EPRT

RARMF vs EPRT: Dividend Comparison 2026

RARMF yields 20000.00% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RARMF wins by $52481917574412746752.00M in total portfolio value
10 years
RARMF
RARMF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full RARMF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — RARMF vs EPRT

📍 RARMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRARMFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RARMF + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RARMF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RARMF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, RARMF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RARMF + EPRT for your $10,000?

RARMF: 50%EPRT: 50%
100% EPRT50/50100% RARMF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

RARMF
No analyst data
Altman Z
-1.7
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RARMF buys
0
EPRT buys
0
No recent congressional trades found for RARMF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRARMFEPRT
Forward yield20000.00% ✓3.92%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$52481917574412746752.00M ✓$63.4K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$12,840.73
Total dividends collected$52448189483771600896.00M ✓$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RARMF vs EPRT ($10,000, DRIP)

YearRARMF PortfolioRARMF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$2,010,700$2,000,000.00$11,205$505.18+$2.00M → RARMF
2$377,983,225$375,831,775.70$12,672$682.46+$377.97M → RARMF
3$66,433,479,469$66,029,037,418.28$14,490$930.48+$66433.46M → RARMF
4$10,916,985,471,987$10,845,901,648,955.73$16,786$1,282.69+$10916985.46M → RARMF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$19,753$1,791.56+$1677384363.75M → RARMF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$23,677$2,541.64+$240985175079.12M → RARMF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$29,008$3,672.99+$32373573631143.66M → RARMF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$36,463$5,425.08+$4066766648320630.00M → RARMF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$47,238$8,221.57+$477730483406513344.00M → RARMF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$63,385$12,840.73+$52481917574412746752.00M → RARMF

RARMF vs EPRT: Complete Analysis 2026

RARMF — Stock

Cadence Minerals Plc identifies, invests in, and develops lithium and rare earth assets. The company is also exploring for iron ore and other mining related opportunities. In addition, it holds interests in the Sonora Lithium project located in Northern Mexico; and Yangibana project situated in Gascoyne, Western Australia; and the Amapa Iron Ore project located in Brazil . The company was formerly known as Rare Earth Minerals plc and changed its name to Cadence Minerals Plc in March 2017. Cadence Minerals Plc was incorporated in 2004 and is based in London, the United Kingdom.

Full RARMF Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this RARMF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RARMF vs SCHDRARMF vs JEPIRARMF vs ORARMF vs KORARMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.